These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 36340303)

  • 1. Management of Alcohol Use Disorder in Patients With Alcoholic Liver Disease.
    Murthy P; Shadakshari D; Mahadevan J; Chand PK
    J Clin Exp Hepatol; 2022; 12(6):1514-1526. PubMed ID: 36340303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Alcohol Withdrawal Syndrome in Patients with Alcoholic Liver Disease.
    Chand PK; Panda U; Mahadevan J; Murthy P
    J Clin Exp Hepatol; 2022; 12(6):1527-1534. PubMed ID: 36340306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.
    Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC
    Med J Aust; 2021 Oct; 215 Suppl 7():S3-S32. PubMed ID: 34601742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of direct ethanol metabolites in assessing alcohol intake in nonintoxicated male patients in an emergency room setting.
    Kip MJ; Spies CD; Neumann T; Nachbar Y; Alling C; Aradottir S; Weinmann W; Wurst FM
    Alcohol Clin Exp Res; 2008 Jul; 32(7):1284-91. PubMed ID: 18540912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum, Screening, and Diagnosis of Alcohol-related Liver Disease.
    Hernandez-Tejero M; Clemente-Sanchez A; Bataller R
    J Clin Exp Hepatol; 2023; 13(1):75-87. PubMed ID: 36647416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcoholics Anonymous and other 12-step programs for alcohol use disorder.
    Kelly JF; Humphreys K; Ferri M
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012880. PubMed ID: 32159228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol use disorder in alcohol-associated liver disease: Two sides of the same coin.
    Singal AK; Leggio L; DiMartini A
    Liver Transpl; 2024 Feb; 30(2):200-212. PubMed ID: 37934047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
    Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
    Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of alcohol use disorder in patients with chronic liver disease.
    Mellinger JL; Fernandez AC; Winder GS
    Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37314739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate-deficient transferrin is a sensitive marker of alcohol consumption in fatty liver disease.
    Morinaga M; Kon K; Uchiyama A; Fukada H; Fukuhara K; Yaginuma R; Nakadera E; Yamashina S; Ikejima K
    Hepatol Int; 2022 Apr; 16(2):348-358. PubMed ID: 35060066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baclofen for the Treatment of Alcohol Use Disorder in Patients With Liver Cirrhosis: 10 Years After the First Evidence.
    Mosoni C; Dionisi T; Vassallo GA; Mirijello A; Tarli C; Antonelli M; Sestito L; Rando MM; Tosoni A; De Cosmo S; Gasbarrini A; Addolorato G
    Front Psychiatry; 2018; 9():474. PubMed ID: 30327620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease: Controversies in Pharmacological Therapy.
    Tarli C; Mirijello A; Addolorato G
    Semin Liver Dis; 2022 May; 42(2):138-150. PubMed ID: 35292951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Medical Treatment for Alcohol-Associated Liver Disease.
    Ayares G; Idalsoaga F; Díaz LA; Arnold J; Arab JP
    J Clin Exp Hepatol; 2022; 12(5):1333-1348. PubMed ID: 36157148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Assessment of the Psychosocial Evaluation for Early Liver Transplantation in Patients With Acute Alcoholic Hepatitis in the Context of Alcohol Use Disorder, a Case-Control Study.
    Dienstag A; Dienstag P; Mohan K; Mirza O; Schubert E; Ford L; Edelman M; Im G; Shenoy A
    Subst Abuse; 2022; 16():11782218221115659. PubMed ID: 35966615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary Care of Alcohol-related Liver Disease and Alcohol Use Disorder: A Narrative Review for Hepatology and Addiction Clinicians.
    Shroff H; Gallagher H
    Clin Ther; 2023 Dec; 45(12):1177-1188. PubMed ID: 37813775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation and alcoholic liver disease: History, controversies, and considerations.
    Marroni CA; Fleck AM; Fernandes SA; Galant LH; Mucenic M; de Mattos Meine MH; Mariante-Neto G; Brandão ABM
    World J Gastroenterol; 2018 Jul; 24(26):2785-2805. PubMed ID: 30018475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
    Klimas J; Fairgrieve C; Tobin H; Field CA; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C; Cullen W
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009269. PubMed ID: 30521696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of alcohol consumption among hepatitis C-positive people receiving opioid maintenance treatment using direct ethanol metabolites and self-report: a pilot study.
    Wurst FM; Haber PS; Wiesbeck G; Watson B; Wallace C; Whitfield JB; Halter C; Weinmann W; Conigrave KM
    Addict Biol; 2008 Sep; 13(3-4):416-22. PubMed ID: 17711559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver Biopsy in Patients With Alcohol-Associated Liver Disease With Acute-on-Chronic Liver Failure.
    Jophlin L; Singal AK
    J Clin Exp Hepatol; 2022; 12(2):544-550. PubMed ID: 35535109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate-deficient transferrin as a marker of alcohol abuse: relationship to alcohol consumption, severity of liver disease, and fibrogenesis.
    Niemelä O; Sorvajärvi K; Blake JE; Israel Y
    Alcohol Clin Exp Res; 1995 Oct; 19(5):1203-8. PubMed ID: 8561291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.